Decades of research have generated knowledge and tools with the potential to prevent all new HIV infections, to ultimately end the HIV epidemic in the United States and worldwide, and to improve the lives of people living with HIV. To date, reality has fallen short of these goals, in part due to pressing unmet needs. The Tennessee Center for AIDS Research (CFAR) is located in the Southeastern United States, the region with the greatest number of new HIV infections, and of persons living with HIV. This CFAR was established in 2015, under the leadership of Prof. Simon Mallal, as a three-way partnership between a research-intensive medical institution (Vanderbilt University Medical Center, VUMC), a historically black medical college (Meharry Medical College, MMC), and an academically engaged state health department (Tennessee Department of Health, TDH). This partnership has fostered collaborations that would be unimaginable without CFAR. For example, results of an analysis by VUMC and MMC investigators using TDH surveillance data has affected statewide public policy and law regarding needle exchange, reducing the likelihood of a potentially devastating HIV outbreak in rural Tennessee. To end the epidemic, it is becoming increasingly important to pursue community-engaged research, to include both people living with HIV and those at high risk. Toward this end, this CFAR has newly partnered with a fourth institution, Nashville CARES, a sophisticated community-based organization with a 25-year exclusive focus on people living with HIV and those at high risk. Through this four-way partnership, our vision is to have transformative, local and global translational impact. Guided by this vision, our mission is to coordinate the complementary institutional and community strengths and resources of VUMC, MMC, TDH and CARES to most effectively reduce the burden of HIV/AIDS and generalize these benefits nationally and globally. Work of this CFAR aligns with National Institutes of Health high priorities for NIH/AIDS research. To fulfill our mission, this CFAR will pursue four specific aims: 1) To support multidisciplinary HIV research that leverages the highly collaborative local environment to build impactful team science among the four institutions of the CFAR; 2) To nurture and support career development of junior investigators, so as to grow the number and diversity of the next generation of HIV researchers; 3) To specifically enable HIV research opportunities for MMC investigators, to include engagement with investigators and resources across the CFAR, and leveraging team science; and 4) To continue to grow a broad emphasis on HIV-focused community-engaged research that pervades the CFAR, and with a focus on ending the epidemic.

Public Health Relevance

Decades of research have generated new knowledge and tools with the potential to prevent all new HIV infections and improve the lives of all persons living with HIV. Unfortunately, reality falls far short of these goals. The Tennessee Center for AIDS Research leverages complementary strengths of its four partner institutions to have broad and substantial impact on the HIV epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI110527-06
Application #
9996151
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
2015-04-01
Project End
2025-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Balasubramaniam, Muthukumar; Zhou, Jing; Addai, Amma et al. (2018) PF74 Inhibits HIV-1 Integration by Altering The Composition of the Preintegration Complex. J Virol :
Tan, Yi; Tsan-Yuk Lam, Tommy; Heberlein-Larson, Lea A et al. (2018) Large scale complete genome sequencing and phylodynamic analysis of eastern equine encephalitis virus reveal source-sink transmission dynamics in the United States. J Virol :
Rickles, Michael; Rebeiro, Peter F; Sizemore, Lindsey et al. (2018) Tennessee's In-state Vulnerability Assessment for a ""Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection"" Event Utilizing Data About the Opioid Epidemic. Clin Infect Dis 66:1722-1732
Koethe, John R; McDonnell, Wyatt; Kennedy, Arion et al. (2018) Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons. J Acquir Immune Defic Syndr 77:e14-e21
Stone Jr, Cosby A; Liu, Yiwei; Relling, Mary V et al. (2018) Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract :
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Leger, Paul; Chirwa, Sanika; Nwogu, Jacinta N et al. (2018) Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenet Genomics 28:1-6
Trubiano, Jason A; Strautins, Kaija; Redwood, Alec J et al. (2018) The Combined Utility of Ex Vivo IFN-? Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. J Allergy Clin Immunol Pract 6:1287-1296.e1
McGoy, Shanell L; Pettit, April C; Morrison, Melissa et al. (2018) Use of Social Network Strategy Among Young Black Men Who Have Sex With Men for HIV Testing, Linkage to Care, and Reengagement in Care, Tennessee, 2013-2016. Public Health Rep 133:43S-51S
Tan, Yi; Pickett, Brett E; Shrivastava, Susmita et al. (2018) Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic. PLoS Negl Trop Dis 12:e0006670

Showing the most recent 10 out of 126 publications